Delisting riskPopularity #4,729
IBO · AMEX · Biotechnology

Impact BioMedical (IBO)

Commercializes health-and-wellness patents and Celios air-purification products.

$0.5425
vs last close−0.01 (−2.38%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported−$0.02−$0.42−$0.11−$1.18−$0.12−$0.42−$0.02−$0.01
Estimate
Surprise

RevenueReportedEstimate

Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported$5.1K$18.0K$7.0K$7.0K$3.0K
Estimate
Surprise

History

Date / PeriodEstimateReportedSurprise
Aug 2026−$0.01
May 2026−$0.02
Mar 2026−$0.42
Nov 2025−$0.12
Aug 2025
May 2025
Mar 2025
Nov 2024

The latest year is open to everyone — the 4 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Aug 7, 2026−$0.01$3.0K−3.5%
May 12, 2026−$0.02$7.0K0.0%
Mar 27, 2026−$0.42$7.0K+1.8%
Nov 7, 2025−$0.12$18.0K+3.1%
Aug 14, 2025
May 14, 2025
Mar 28, 2025
Nov 12, 2024

The latest year is open to everyone — the 4 quarters behind it read with an account.